FIELD: medicine, pharmacy. SUBSTANCE: lyophilizate has buffer, alanine and mannitol at molar ratio alanine : mannitol = 1:(0.1-1). Enzyme urate oxidase, hormone hGH, interleukin-12 can be used as protein and phosphate buffer as a buffer. Alanine can be in crystalline form and mannitol - in an amorphous one. Protein containing in the composition retains stability at the room temperature. Water content in lyophilizate is compatible with protein activity retention. Invention can be used for making protein-containing preparations. EFFECT: improved quality and properties of the composition. 8 cl, 5 dwg, 5 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE LYOPHILIZED PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2163801C2 |
| PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM | 2017 |
|
RU2678203C2 |
| METHOD FOR PREPARING LYOPHILISED ANTIVIRAL AGENT | 2010 |
|
RU2454221C2 |
| PHARMACEUTICAL COMPOSITION REGULATING HEMATOPOIESIS | 1991 |
|
RU2100032C1 |
| PHARMACEUTICAL COMPOSITIONS WITH NERVE GROWTH FACTORS | 1994 |
|
RU2126265C1 |
| METHOD FOR PRODUCING ERYTHROPOIETIN FORMS USEABLE FOR INJECTIONS | 1988 |
|
RU2043118C1 |
| METHOD FOR FREEZE DRYING PHARMACEUTICAL PREPARATIONS | 2011 |
|
RU2476790C2 |
| BIS(THIO-HYDRAZIDE AMIDE) COMPOSITION | 2006 |
|
RU2433822C2 |
| METHODS, COMPOSITIONS AND SETS FOR LYOPHILISATION | 2010 |
|
RU2540480C2 |
| PHARMACEUTICAL PREPARATION CONTAINING GROWTH HORMONE OR GROWTH HORMONE DERIVATIVE AND HISTIDINE OR HISTIDINE DERIVATIVE, A PREPARATION THAT IS GROWTH HORMONE CRYSTALS CONTAINING HISTIDINE OR HISTIDINE DERIVATIVE AND A METHOD OF PREPARING GROWTH HORMONE CRYSTALS AND HISTIDINE OR HISTIDINE DERIVATIVE | 1992 |
|
RU2122426C1 |
